$48.56
-3.22 (-6.21%)
Analyst Consensus
Buy
28
Analysts
High
Coverage
Price Target
Analyst Price Target
+128.7% upside
Low Target
$83.97
Average Target
$111.08
High Target
$162.31
Current Price
$48.56
Current
$48.56
$48.56
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Scenario Analysis
Bear Case
$83.97
72.9%
Low target
Base Case
$111.08
+128.7%
Avg target
Bull Case
$162.31
+234.2%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$65.98
-26.4% from high
52-Week Low
$44.12
+10.1% from low
50-Day SMA
$53.67
-9.5% vs SMA
200-Day SMA
$52.84
-8.1% vs SMA
RSI (14)
50.8
Neutral
Target vs 52W High
$111.08
+68.4% vs high
Next Earnings Report
Nov 9, 2026
2d
until earnings
EPS Est: $-1.06
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |